Skip To Content

Talis Biomedical Corporation Securities Litigation

1-877-331-0411

This official website is maintained by the Claims Administrator under the supervision of Lead Counsel in the action titled In re Talis Biomedical Securities Litigation, No. 22-cv-00105-SI (the “Action”) which is pending in the United States District Court for the Northern District of California (the “Court”).
*** Final Approval Granted ***

On March 21, 2025, the Court held a Final Approval Hearing and granted the Final Judgement Approving the Settlement as well as the Order Approving the Plan of Allocation and the Order Awarding Attorneys' Fees, Litigation Expenses, as found on the Court Documents section of this website. 

Contact Us

If you have any questions that have not been answered by the information included on this website or in the Notice, please contact the Claims Administrator.

Talis Securities Litigation Helpline: 1-877-331-0411
By email: info@TalisSecuritiesLitigation.com

Or in writing to:

Talis Biomedical Corporation Securities Litigation
c/o A.B. Data, Ltd.
P.O. Box 173064
Milwaukee, WI 53217